A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin Front Cell Dev Biol
CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma Blood
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications FRONT MED-LAUSANNE
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy EMBO J
Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study FRONT MED-LAUSANNE
Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development Front Immunol